DHX37
Basic information
Region (hg38): 12:124946825-124989131
Previous symbols: [ "DDX37" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies (Limited), mode of inheritance: AR
- 46,XY complete gonadal dysgenesis (Supportive), mode of inheritance: AD
- testicular regression syndrome (Supportive), mode of inheritance: AR
- 46,XY partial gonadal dysgenesis (Supportive), mode of inheritance: AD
- neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies (Strong), mode of inheritance: AR
- 46,XY sex reversal 11 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
46, XY sex reversal 11; Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies | AD/AR | Cardiovascular; Genitourinary; Oncologic | Among other findings, individuals with Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies have been reported as affected with arrhythmia and other cardiovascular anomalies, and awareness may allow prompt diagnosis and management; In 46, XY sex reversal 11, individuals may be at risk of gonadal neoplasms, and awareness may allow appropriate management | Cardiovascular; Genitourinary; Musculoskeletal; Neurologic | 26539891; 31256877; 31287541; 31337883 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- DHX37-related disorder (1 variants)
- Arginase deficiency (1 variants)
- 46,XY sex reversal 11 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHX37 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 71 | 16 | 88 | |||
missense | 185 | 14 | 15 | 221 | ||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 8 | 11 | 9 | 28 | ||
non coding | 48 | 20 | 72 | |||
Total | 1 | 8 | 200 | 134 | 53 |
Highest pathogenic variant AF is 0.0000131
Variants in DHX37
This is a list of pathogenic ClinVar variants found in the DHX37 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-124947817-G-C | Likely benign (Sep 03, 2022) | |||
12-124947834-C-T | Likely benign (Jun 24, 2023) | |||
12-124947836-A-G | DHX37-related disorder | Likely benign (Jan 09, 2024) | ||
12-124947840-C-T | Uncertain significance (Jun 09, 2022) | |||
12-124947849-T-C | Uncertain significance (Aug 04, 2023) | |||
12-124947851-G-C | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
12-124947869-C-T | Inborn genetic diseases | Uncertain significance (Sep 26, 2022) | ||
12-124947886-G-T | Uncertain significance (Mar 28, 2023) | |||
12-124947898-G-A | Benign (Jan 22, 2024) | |||
12-124948072-G-A | Benign (Jan 26, 2024) | |||
12-124948145-C-G | Likely benign (Feb 20, 2023) | |||
12-124948150-C-A | Benign (Jan 11, 2024) | |||
12-124948159-G-A | Uncertain significance (Jan 08, 2024) | |||
12-124948166-C-T | Likely benign (Aug 17, 2022) | |||
12-124948170-C-A | Uncertain significance (Sep 27, 2022) | |||
12-124948170-C-T | Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies • Inborn genetic diseases | Uncertain significance (Jul 20, 2021) | ||
12-124948171-G-A | Uncertain significance (Jan 01, 2024) | |||
12-124948201-G-A | Likely benign (Sep 30, 2023) | |||
12-124949971-C-T | Likely benign (Jan 12, 2024) | |||
12-124949974-C-A | Likely benign (Apr 14, 2022) | |||
12-124949974-C-T | Likely benign (Aug 30, 2023) | |||
12-124949975-G-A | Likely benign (Nov 08, 2022) | |||
12-124949978-G-A | Likely benign (Apr 23, 2023) | |||
12-124949993-A-G | Uncertain significance (Jan 22, 2024) | |||
12-124949995-G-A | Neurodevelopmental delay;Intellectual disability • Neurodevelopmental disorders | Likely pathogenic (May 30, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DHX37 | protein_coding | protein_coding | ENST00000308736 | 27 | 42298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.993 | 0.00748 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 594 | 733 | 0.810 | 0.0000502 | 7384 |
Missense in Polyphen | 160 | 255.97 | 0.62507 | 2386 | ||
Synonymous | 0.537 | 314 | 326 | 0.962 | 0.0000249 | 2378 |
Loss of Function | 5.89 | 10 | 58.7 | 0.170 | 0.00000301 | 686 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000896 | 0.0000879 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000183 | 0.000163 |
dbNSFP
Source:
- Pathway
- rRNA processing;Metabolism of RNA;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol
(Consensus)
Recessive Scores
- pRec
- 0.0993
Intolerance Scores
- loftool
- 0.376
- rvis_EVS
- -1.05
- rvis_percentile_EVS
- 7.64
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- Y
- hipred_score
- 0.611
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.805
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Dhx37
- Phenotype
Zebrafish Information Network
- Gene name
- dhx37
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing
- Cellular component
- nucleus;nucleoplasm;nucleolus
- Molecular function
- RNA binding;ATP binding;ATP-dependent 3'-5' RNA helicase activity